Placental Enzyme AOC1 Times Labor via Spermidine and Autophagy
Scientists uncover how a placental enzyme controls birth timing through spermidine metabolism and cellular self-cleaning, pointing to preterm birth therapies.
Summary
Researchers discovered that placental AOC1 enzyme degrades spermidine to regulate autophagy in trophoblast cells, controlling the timing of labor. When AOC1 is low, spermidine accumulates, triggering autophagy via EIF5A hypusination, which reduces estrogen and prostaglandin production needed for labor onset. Estrogen in turn boosts AOC1 expression through ERα and SRC-1/2 coactivators, forming a homeostatic feedback loop. AOC1 is elevated in both mouse and human preterm labor placentas. Placenta-specific AOC1 knockout significantly delayed labor in mice, while spermidine supplementation rescued inflammation-induced preterm birth, suggesting a novel therapeutic strategy.
Detailed Summary
Preterm birth affects 5–15% of pregnancies worldwide and remains the leading cause of neonatal death, yet its molecular triggers are poorly understood. This study set out to identify placenta-derived signals governing parturition timing, using a mouse model in which fetuses doubly deficient in steroid receptor coactivators SRC-1 and SRC-2 (Src-1/−2 dKO) are born 1–2 days late.
RNA sequencing of placentas at 18.5 days post-coitum revealed that amine oxidase copper-containing 1 (AOC1) was the most consistently downregulated gene unique to the double-knockout condition. AOC1 normally catabolizes polyamines including spermidine; its reduction caused spermidine to accumulate in dKO placentas. The team then showed that elevated spermidine drives autophagy in placental trophoblast cells specifically through hypusination of the translation factor EIF5A—a post-translational modification where spermidine donates an aminobutyl group to a conserved lysine residue. Hypusinated EIF5A promotes autophagic flux, which in turn suppresses the synthesis of estrogen and prostaglandins, hormones critical for triggering uterine contractions and labor onset.
A key mechanistic insight was the discovery of a feedback loop: estrogen, acting via estrogen receptor-α (ERα) together with SRC-1/2 coactivators, transcriptionally upregulates AOC1 expression. This loop normally keeps placental autophagy in check—sufficient to maintain cellular homeostasis without suppressing hormone production so severely that labor is prevented. When AOC1 falls (as in the dKO model), spermidine rises, autophagy increases, hormone output drops, and labor is delayed.
Physiological and clinical relevance was established on multiple fronts. AOC1 protein levels were found to be dynamically elevated in placentas from preterm labor cases in both mice and humans compared with term controls. Placenta-specific Aoc1 knockdown or knockout in otherwise normal mice dramatically delayed labor, confirming AOC1's causal role. Conversely, spermidine supplementation in LPS-induced preterm birth mice rescued premature delivery, demonstrating that restoring spermidine-driven autophagy has therapeutic potential for preterm labor.
The study establishes the placental AOC1–spermidine–EIF5A hypusination–autophagy axis as a central determinant of parturition timing. Beyond reproductive biology, this work connects polyamine metabolism and protein hypusination—topics well-studied in aging and longevity research—to a physiological process of enormous clinical importance, and opens new avenues for pharmacological intervention in preterm birth.
Key Findings
- AOC1 downregulation in Src-1/−2 dKO placentas increases spermidine, inducing trophoblast autophagy and delaying labor.
- Spermidine drives autophagy via EIF5A hypusination, suppressing placental estrogen and prostaglandin production.
- Estrogen reciprocally upregulates AOC1 via ERα/SRC-1/2, forming a homeostatic feedback loop controlling autophagy.
- AOC1 is elevated in placentas of preterm labor cases in both mice and humans.
- Spermidine supplementation rescued LPS-induced preterm birth in mice, suggesting a therapeutic strategy.
Methodology
The study used RNA-seq of placentas from WT, Src-1 KO, Src-2 KO, and Src-1/−2 dKO mouse fetuses at 18.5 dpc, validated by RT-qPCR, western blotting, and immunohistochemistry. Mechanistic studies employed trophoblast cell culture with spermidine treatment, EIF5A hypusination assays, and placenta-specific Aoc1 knockout mice, with LPS-induced preterm birth rescue experiments using spermidine supplementation in vivo.
Study Limitations
Findings are primarily from mouse models, and while human placental data support the pathway's conservation, direct functional validation in human tissue or clinical trials is lacking. The precise mechanisms by which autophagy suppresses estrogen and prostaglandin synthesis, and potential off-target effects of spermidine supplementation on other organs, require further investigation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: